Skip to main content

Table 3 Comparison of baseline characteristics between the two groups

From: The effects of adjunctive treatment with l-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial

Parameters

l-Carnitine group (n=24)

Data: mean (SD)

Control group (n=27)

Data: mean (SD)

P-value1

Age (years)

57.46 ± 14.44

58.22 ± 15.41

0.85

Sex

Men

14

15

0.842

Women

10

12

Body weight (kg) (IBW)

67.91 (10.07)

65.18 (16.08)

0.47

Energy received (kcal)

898.33 (233.23)

871.11 (237.24)

0.68

Protein (g)

56.14 (14.57)

54.44 (14.82)

0.68

Carbohydrate (g)

91.38 (23.78)

88.54 (24.28)

0.67

Fat (g)

36.49 (9.08)

35.42 (9.25)

0.68

SOFA score

8.50 (2.43)

8.25 (2.21)

0.71

NUTRIC score

5.66 (1.60)

6.11 (1.60)

0.32

WBC

11.54 (10.69)

10.14 (4.53)

0.354

Hb

10.18 (2.39)

9.60 (1.69)

0.321

PLT

219.54 (142.56)

203.74 (91.10)

0.636

PT

15.40 (5.75)

15.30 (4.55)

0.943

PTT

32.87 (6.98)

46.29 (43.46)

0.125

INR

1.44 (0.72)

1.39 (0.54)

0.808

FBG

141.79 (64.53)

122.85 (59.11)

0.279

BUN

70.58 (63.80)

66.26 (39.18)

0.769

Cr

1.37 (0.83)

1.53 (0.76)

0.467

Na

139.29 (9.59)

137.56 (7.71)

0.477

K

3.97 (0.48)

3.77 (0.60)

0.198

Ca

8.33 (0.89)

8.59 (0.50)

0.229

Mg

2.09 (0.34)

2.19 (0.60)

0.493

PH

3.30 (1.44)

3.43 (1.15)

0.722

ALT (SGPT)

41.42 (37.65)

53.53 (68.13)

0.444

AST (SGOT)

52.88 (46.50)

55.54 (59.06)

0.860

Total bilirubin

1.24 (0.81)

0.63 (0.21)

0.001

Direct bilirubin

0.57 (0.45)

0.29 (0.13)

0.007

Lactate

12.93 (6.28)

10.71 (4.38)

0.146

Alb

3.05 (0.40)

3.12 (0.48)

0.608

Total protein

5.11 (0.74)

5.16 (1.07)

0.858

  1. 1Resulted from independent samples t-test for continuous and chi-squared test for categorical variables